Cargando…

Clinical Outcomes After Bilateral Implantation of a Trifocal Presbyopia-Correcting Intraocular Lens in an Indian Population

PURPOSE: To evaluate the effectiveness and safety of a presbyopia-correcting trifocal intraocular lens (IOL), AcrySof(®) IQ PanOptix(®) (TFNT00), in an Indian population. PATIENTS AND METHODS: This prospective, multicenter, observational, single-arm, post-marketing study included 67 patients undergo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramamurthy, Dandapani, Vasavada, Abhay, Padmanabhan, Prema, Reddy, Jagadesh C, Shetty, Naren, Dey, Arindam, Sudhir, Rachapalle Reddi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837564/
https://www.ncbi.nlm.nih.gov/pubmed/33519183
http://dx.doi.org/10.2147/OPTH.S279001
_version_ 1783642980655038464
author Ramamurthy, Dandapani
Vasavada, Abhay
Padmanabhan, Prema
Reddy, Jagadesh C
Shetty, Naren
Dey, Arindam
Sudhir, Rachapalle Reddi
author_facet Ramamurthy, Dandapani
Vasavada, Abhay
Padmanabhan, Prema
Reddy, Jagadesh C
Shetty, Naren
Dey, Arindam
Sudhir, Rachapalle Reddi
author_sort Ramamurthy, Dandapani
collection PubMed
description PURPOSE: To evaluate the effectiveness and safety of a presbyopia-correcting trifocal intraocular lens (IOL), AcrySof(®) IQ PanOptix(®) (TFNT00), in an Indian population. PATIENTS AND METHODS: This prospective, multicenter, observational, single-arm, post-marketing study included 67 patients undergoing cataract surgery with bilateral implantation of TFNT00 across five Indian sites. Postoperative outcomes were assessed at 3 months after second eye surgery. Effectiveness outcomes included: mean binocular and monocular visual acuity (VA) at distance (4 m), intermediate (60 cm), and near (40 cm); binocular defocus curve; manifest refraction; and subjective symptom questionnaire evaluation. Safety outcomes included the rate of ocular adverse events and mesopic contrast sensitivity. RESULTS: Mean binocular and monocular distance-corrected and uncorrected VAs of 0.1 logMAR or better (approximately 20/25 Snellen) were achieved at distance, intermediate, and near. Overall, ≥70% of patients achieved binocular 0.1 logMAR vision or better across all distances. TFNT00 maintained a mean VA of 0.1 logMAR or better at the defocus range of +0.5 diopters (D) to –2.5 D (200 cm to 40 cm). The subjective symptom questionnaire-assessed frequency of halo visual disturbances was low at Month 3; halos were reported “none of the time” to “only some of the time” in 86.6% of patients. The large majority of patients (98.5%) were “satisfied” or “very satisfied” with their near, intermediate, and distance vision at Month 3, and ≥94.0% of patients reported spectacle independence for tasks at all distances. The adverse event rate was low; no patients discontinued due to an adverse event. CONCLUSION: TFNT00 provided a continuous range of vision of 20/25 or better for distance to near and performed effectively at an intermediate functional distance of 60 cm, resulting in high levels of spectacle independence and patient satisfaction. TFNT00 demonstrated a good safety profile and a low post-operative frequency of halo visual disturbances.
format Online
Article
Text
id pubmed-7837564
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78375642021-01-28 Clinical Outcomes After Bilateral Implantation of a Trifocal Presbyopia-Correcting Intraocular Lens in an Indian Population Ramamurthy, Dandapani Vasavada, Abhay Padmanabhan, Prema Reddy, Jagadesh C Shetty, Naren Dey, Arindam Sudhir, Rachapalle Reddi Clin Ophthalmol Original Research PURPOSE: To evaluate the effectiveness and safety of a presbyopia-correcting trifocal intraocular lens (IOL), AcrySof(®) IQ PanOptix(®) (TFNT00), in an Indian population. PATIENTS AND METHODS: This prospective, multicenter, observational, single-arm, post-marketing study included 67 patients undergoing cataract surgery with bilateral implantation of TFNT00 across five Indian sites. Postoperative outcomes were assessed at 3 months after second eye surgery. Effectiveness outcomes included: mean binocular and monocular visual acuity (VA) at distance (4 m), intermediate (60 cm), and near (40 cm); binocular defocus curve; manifest refraction; and subjective symptom questionnaire evaluation. Safety outcomes included the rate of ocular adverse events and mesopic contrast sensitivity. RESULTS: Mean binocular and monocular distance-corrected and uncorrected VAs of 0.1 logMAR or better (approximately 20/25 Snellen) were achieved at distance, intermediate, and near. Overall, ≥70% of patients achieved binocular 0.1 logMAR vision or better across all distances. TFNT00 maintained a mean VA of 0.1 logMAR or better at the defocus range of +0.5 diopters (D) to –2.5 D (200 cm to 40 cm). The subjective symptom questionnaire-assessed frequency of halo visual disturbances was low at Month 3; halos were reported “none of the time” to “only some of the time” in 86.6% of patients. The large majority of patients (98.5%) were “satisfied” or “very satisfied” with their near, intermediate, and distance vision at Month 3, and ≥94.0% of patients reported spectacle independence for tasks at all distances. The adverse event rate was low; no patients discontinued due to an adverse event. CONCLUSION: TFNT00 provided a continuous range of vision of 20/25 or better for distance to near and performed effectively at an intermediate functional distance of 60 cm, resulting in high levels of spectacle independence and patient satisfaction. TFNT00 demonstrated a good safety profile and a low post-operative frequency of halo visual disturbances. Dove 2021-01-22 /pmc/articles/PMC7837564/ /pubmed/33519183 http://dx.doi.org/10.2147/OPTH.S279001 Text en © 2021 Ramamurthy et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Ramamurthy, Dandapani
Vasavada, Abhay
Padmanabhan, Prema
Reddy, Jagadesh C
Shetty, Naren
Dey, Arindam
Sudhir, Rachapalle Reddi
Clinical Outcomes After Bilateral Implantation of a Trifocal Presbyopia-Correcting Intraocular Lens in an Indian Population
title Clinical Outcomes After Bilateral Implantation of a Trifocal Presbyopia-Correcting Intraocular Lens in an Indian Population
title_full Clinical Outcomes After Bilateral Implantation of a Trifocal Presbyopia-Correcting Intraocular Lens in an Indian Population
title_fullStr Clinical Outcomes After Bilateral Implantation of a Trifocal Presbyopia-Correcting Intraocular Lens in an Indian Population
title_full_unstemmed Clinical Outcomes After Bilateral Implantation of a Trifocal Presbyopia-Correcting Intraocular Lens in an Indian Population
title_short Clinical Outcomes After Bilateral Implantation of a Trifocal Presbyopia-Correcting Intraocular Lens in an Indian Population
title_sort clinical outcomes after bilateral implantation of a trifocal presbyopia-correcting intraocular lens in an indian population
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837564/
https://www.ncbi.nlm.nih.gov/pubmed/33519183
http://dx.doi.org/10.2147/OPTH.S279001
work_keys_str_mv AT ramamurthydandapani clinicaloutcomesafterbilateralimplantationofatrifocalpresbyopiacorrectingintraocularlensinanindianpopulation
AT vasavadaabhay clinicaloutcomesafterbilateralimplantationofatrifocalpresbyopiacorrectingintraocularlensinanindianpopulation
AT padmanabhanprema clinicaloutcomesafterbilateralimplantationofatrifocalpresbyopiacorrectingintraocularlensinanindianpopulation
AT reddyjagadeshc clinicaloutcomesafterbilateralimplantationofatrifocalpresbyopiacorrectingintraocularlensinanindianpopulation
AT shettynaren clinicaloutcomesafterbilateralimplantationofatrifocalpresbyopiacorrectingintraocularlensinanindianpopulation
AT deyarindam clinicaloutcomesafterbilateralimplantationofatrifocalpresbyopiacorrectingintraocularlensinanindianpopulation
AT sudhirrachapallereddi clinicaloutcomesafterbilateralimplantationofatrifocalpresbyopiacorrectingintraocularlensinanindianpopulation